mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
mRNA |
BRD-K13185470 |
CTRPv2 |
pan-cancer |
AAC |
-0.0087 |
0.9 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
mRNA |
CP466722 |
GDSC1000 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
0.9 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.004 |
0.9 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |